IGMS
IGM Biosciences
IGMS
IGMS
Delisted
IGMS was delisted on the 13th of August, 2025.
72 hedge funds and large institutions have $183M invested in IGM Biosciences in 2023 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 21 increasing their positions, 21 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
9% less funds holding
Funds holding: 79 → 72 (-7)
29% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 24
Holders
72
Holding in Top 10
–
Calls
$222K
Puts
$32K
Top Buyers
| 1 | +$4.85M | |
| 2 | +$4.8M | |
| 3 | +$4.43M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$3.32M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.6M |
Top Sellers
| 1 | -$5.14M | |
| 2 | -$4.33M | |
| 3 | -$3.79M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.64M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$2.18M |